Looking for volunteers
Prostate Single Port & Laser Enucleation Comparison Trial
NCT06224218 · University of Illinois at Chicago · Updated 16 May 2024
- What is being tested
- Single Port Robotic Surgery; Laser Surgery
- For
- Prostate Hyperplasia
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 88 years. About 116 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 15 Jan 2024, ends 15 Aug 2027. Registered 25 Jan 2024.
- Results
- None posted yet.
In the researchers' words
Surgical treatments for benign prostatic hyperplasia (BPH) are necessary when non-procedural approaches fail to alleviate lower urinary tract symptoms (LUTS) or bladder outlet obstruction (BOO). Open simple prostatectomy and laser enucleation are recommended for prostatic adenoma size greater than 80 ml. Minimally invasive approaches, such as robotic-assisted simple prostatectomy, have gained popularity due to their comparable outcomes with lower morbidity. The introduction of the da Vinci single-port (SP) robotic platform offers potential advantages, but its outcomes have not been thoroughly investigated. This randomized controlled trial aims to compare the outcomes of SP simple prostatectomy performed using the da Vinci robotic platform versus thulium laser enucleation of the prostate for the treatment of BPH and BOO.
Sites
- UI Health SCB Clinic Department of UrologyChicago, Illinois, United States